Announced Mon, 29 Jun · 16:02 IST
Lasa Supergenerics: Trading Window Closes July 1 for Q1 FY27 Results
Compliance View source PDF
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.3%1-day move
₹7.62
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-0.3-4.9-3.0-4.1-4.2-2.2-3.5———
Up moveDown movePending
AI summary
The company has informed the exchanges that the trading window for its equity shares is closed for designated employees and their immediate relatives starting July 1, 2026. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). This is a routine compliance intimation under SEBI insider trading regulations and indicates that Q1 results are due soon.
Likely market impact
Routine SEBI compliance filing with no direct impact on retail shareholders. Suggests Q1 FY27 earnings announcement is imminent.